RCMNY
Rubric Capital Management (New York)’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151M | Sell |
10,749,457
-217,215
| -2% | -$3.05M | 2.28% | 10 |
|
|
2025
Q1 | $172M | Hold |
10,966,672
| – | – | 3.07% | 8 |
|
|
2024
Q4 | $153M | Hold |
10,966,672
| – | – | 1.96% | 9 |
|
|
2024
Q3 | $102M | Buy |
10,966,672
+1,150,000
| +12% | +$10.7M | 1.66% | 11 |
|
|
2024
Q2 | $91.3M | Buy |
9,816,672
+2,306,672
| +31% | +$21.5M | 2.39% | 12 |
|
|
2024
Q1 | $74.4M | Buy |
7,510,000
+865,470
| +13% | +$8.58M | 2.2% | 13 |
|
|
2023
Q4 | $21.5M | Buy |
6,644,530
+1,610,000
| +32% | +$5.2M | 0.45% | 36 |
|
|
2023
Q3 | $26.7M | Buy |
5,034,530
+150,000
| +3% | +$797K | 1% | 30 |
|
|
2023
Q2 | $46.5M | Buy |
4,884,530
+1,384,530
| +40% | +$13.2M | 1.99% | 21 |
|
|
2023
Q1 | $38.5M | Buy |
3,500,000
+757,481
| +28% | +$8.33M | 1% | 27 |
|
|
2022
Q4 | $40.6M | Buy |
2,742,519
+2,270,472
| +481% | +$33.6M | 1.77% | 21 |
|
|
2022
Q3 | $9.02M | Buy |
472,047
+245,701
| +109% | +$4.7M | 0.45% | 47 |
|
|
2022
Q2 | $4.82M | Buy |
+226,346
| New | +$4.82M | 0.25% | 62 |
|